Dermata Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions.
Dermata Therapeutics stock last closed at $1.29, down 4.44% from the previous day, and has decreased 88.56% in one year. It has underperformed other stocks in the Biotechnology industry by 0.79 percentage points. Dermata Therapeutics stock is currently +5.74% from its 52-week low of $1.22, and -91.18% from its 52-week high of $14.63.
There are currently 1.32M DRMA shares outstanding. The market value of DRMA is $1.70M. In the last 24 hours, 67,080 DRMA shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy DRMA stock.
Based on our experience, eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountNow that you've picked your brokerage, you need to fill out some personal info so you are able to buy DRMA stock today.
Now that you've created your account on the greatest app to buy stocks, you need to deposit funds:
Watch the walkthrough below for more details transferring money into your brokerage account.
Once you have chosen the best place to buy Dermata Therapeutics stock, it's absolutely critical to analyze their stock before you invest, so you actually wrap your head around the risk and opportunity.
WallStreetZen was designed to help average investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on DRMA's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge DRMA's true value.
Using relative valuations measures:
You can access more valuation analysis on DRMA's stock here.
Out of 1 Equities analysts who track DRMA, the consensus analyst rating on DRMA is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Dermata Therapeutics stock forecast page.
In the last year, executives and large shareholders at DRMA have not bought or sold any shares.
Research more about who owns DRMA shares here.
No, Dermata Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two main types of orders:
Click the Open Trade button and eToro will execute the order.
If you want more info about buying stocks on eToro, watch the how to video below:
Now that you own some DRMA stock, you'll want to keep up with your investment.
Put DRMA on a watchlist to see the latest developments about your DRMA stock.
To reiterate, here are the 6 steps for buying Dermata Therapeutics stock:
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Dermata Therapeutics, create your watchlist below.